Related Experiment Videos
Functional and structural damage in Leishmania mexicana exposed to the cationic peptide dermaseptin
1Departamento de Biologia Celular, Universidad Central de Venezuela, Caracas.
Abstract:
The effect of dermaseptin (DS), a 34 amino acid residue cationic peptide isolated from Phyllomedusa sauvagii skin, has been studied on promastigotes of Leishmania mexicana growing in vitro. Within 5 min of incubation in the presence of DS, the flagellated parasites lost their motility. DS inhibited promastigote growth by 50% at a concentration of 3 microM and by 100% at 10 microM. Immunocytochemical, freeze fracture, label fracture and electron microscopic observations have shown that the amphipathic peptide generates perturbations of the lipid bilayer leading to altered permeability of the surface membrane and death of the parasite.
Insights
Dermaseptin, a peptide from frog skin, effectively kills Leishmania parasites by disrupting their cell membranes. This research shows its potential as an anti-Leishmania agent.
Area of Science:
- Antimicrobial peptides
- Parasitology
- Cell biology
Background:
- Leishmania mexicana is a parasite causing leishmaniasis.
- Dermaseptin (DS) is a cationic peptide from Phyllomedusa sauvagii.
- Antimicrobial peptides are investigated for therapeutic potential.
Purpose of the Study:
- To investigate the effect of dermaseptin on Leishmania mexicana promastigotes.
- To determine the mechanism of action of dermaseptin against these parasites.
Main Methods:
- In vitro culture of Leishmania mexicana promastigotes.
- Treatment with varying concentrations of dermaseptin.
- Motility assays.
- Growth inhibition assays.
- Electron microscopy (immunocytochemistry, freeze fracture, label fracture).
Main Results:
- Dermaseptin rapidly inhibited parasite motility within 5 minutes.
- DS inhibited promastigote growth by 50% at 3 microM and 100% at 10 microM.
- Microscopic analysis revealed membrane perturbations and altered permeability.
Conclusions:
- Dermaseptin exhibits potent anti-Leishmania activity.
- The peptide acts by disrupting the parasite's surface membrane.
- DS demonstrates potential as a therapeutic agent against Leishmania infections.